U.S. Consumer Services Stock News

Why this leadership change at Addus HomeCare matters for investors Addus HomeCare (ADUS) has drawn fresh attention after announcing that President and Chief Operating Officer Heather Dixon is no longer with the company. Former executive Brad Bickham is returning as interim COO for one year. This type of leadership shift can focus investors on how stable they believe the company’s direction is. It can also raise questions about how closely future decisions will align with the approach that...

US small business optimism recently reached a multi month high, which shows many founders remain confident enough to keep hiring, spending and backing their own ideas with time and capital. That is where founder led stocks start to stand out. When leaders think like long term owners, incentives are clearer. This article walks through 3 founder led companies from our screener that could deserve a closer look now. The 3 founder led stocks below are just a sample from our wider screen, which...

Ares Management has delivered a 131.2% gain over the past 5 years, yet the current valuation checks point to the stock trading at a premium to its intrinsic value estimate. The Excess Returns model and market multiple signals both indicate that Ares Management is pricing in strong expectations after a period of solid long term performance. Over the past 5 years, Ares Management has returned 131.2%, which means long term holders have already seen a substantial payoff from owning the...

Shift4 Payments (FOUR) drew fresh attention after reporting second quarter 2026 results that combined higher sales with lower earnings, along with a reduction in full year guidance linked to Middle East travel disruption and currency pressures. See our latest analysis for Shift4 Payments. That reset in guidance has fed directly into the share price, which closed at US$41.04 after a 1 day share price return that declined 4.91%, a 7 day share price return that declined 26.20%, and a 1 year...

Why Insulet’s latest earnings and outlook matter for investors Insulet (PODD) recently reported second quarter 2026 results that showed higher sales, revenue and net income compared with a year earlier, alongside stronger earnings per share from continuing operations. The company also issued new guidance that points to total GAAP revenue growth expectations in the high teens for the upcoming quarter and just above 20% for the full 2026 year. See our latest analysis for Insulet. Despite the...

W.W. Grainger stock has delivered a very strong 5 year run, yet both the Discounted Cash Flow (DCF) intrinsic value estimate and the earnings multiple checks currently point to the shares trading at a premium rather than as a clear bargain. W.W. Grainger has returned 213.8% over 5 years, which puts extra focus on whether the current price still gives investors enough compensation for risk. Recent strong results and an increased outlook can support high expectations for revenue and earnings...

Incyte (INCY) is in focus after the European Commission approved Opzelura cream for adults with moderate atopic dermatitis who are not well served by existing topical therapies. This new indication broadens Opzelura’s approved uses in Europe. See our latest analysis for Incyte. Incyte’s regulatory win comes after a period of firm positive momentum. The share price delivered a 22.52% 90 day share price return and a 48.35% 1 year total shareholder return from a US$121.07 starting point. If you...

SouthState Bank stock has delivered a strong 77.2% return over the past five years, yet on current checks it still screens as undervalued based on both an Excess Returns intrinsic value estimate and market multiples. For investors, that mix raises the question of whether the current price already reflects the good news or if there is still a margin between market price and intrinsic value. Over the last five years, SouthState Bank has returned 77.2%, which is a solid payoff for shareholders...

Royalty Pharma earnings highlight mixed quarterly picture Royalty Pharma (RPRX) reported second quarter 2026 results with revenue of US$674.14 million and net income of US$17.88 million. The six-month figures showed higher revenue and net income compared with the same period a year earlier. See our latest analysis for Royalty Pharma. Royalty Pharma's share price has risen strongly with a year to date share price return of 48.71%, while the 1 year total shareholder return of 64.61% points to...

PHINIA Inc. recently reported past second-quarter 2026 results showing sales of US$940 million and net income of US$40 million, refined its full-year 2026 outlook to net sales of US$3.57–3.67 billion and net earnings of US$155–180 million, and continued sizable share repurchases alongside a US$0.30 quarterly dividend declaration. Together, these updates underline PHINIA’s focus on balancing shareholder cash returns with earnings growth and potential acquisitions in commercial vehicle,...

Hewlett Packard Enterprise stock has delivered very strong 5 year returns, yet the current valuation picture is split, with a Discounted Cash Flow (DCF) intrinsic value suggesting the shares trade at a discount while market based multiples lean the other way. Hewlett Packard Enterprise has returned 319.8% over the past 5 years, which puts extra focus on whether today’s price still leaves room for a reasonable margin of safety. Investor expectations today are heavily influenced by demand for...

In the past few days, Fastenal reported quarterly results with earnings per share matching expectations and revenue coming in ahead of forecasts, while analysts maintained a mixed, generally cautious stance with a consensus Hold rating. This combination of solid top-line performance and sharply divided analyst opinions is drawing renewed attention to how Fastenal’s business model may respond to current industrial demand conditions. Next, we’ll examine how Fastenal’s in-line earnings but...

General Motors stock has delivered a very strong 176.7% return over the past three years, yet the current valuation checks send mixed messages, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to a discount while market based multiples suggest the shares are not obviously cheap. Over the past three years, General Motors has returned 176.7%, which puts extra focus on whether the recent share price reflects a sustainable earnings and cash flow profile. Recent moves to...

Vera Therapeutics (VERA) drew investor attention after receiving accelerated FDA approval for TRUTAKNA for adult patients with primary IgA nephropathy at risk of disease progression, alongside releasing its latest quarterly financial results. See our latest analysis for Vera Therapeutics. Despite the recent regulatory progress, Vera Therapeutics’ share price has been under pressure, with a 30 day share price return down 27.88% and a year to date share price return down 37.70%. At the same...

Absci stock reaction to ABS-201 trial update and earnings Absci (ABSI) drew fresh attention after releasing interim Phase 1 data for ABS-201 and reporting second quarter results, giving you new information on both its clinical pipeline and current financial profile. See our latest analysis for Absci. Absci’s 1-day share price return of 4.44% and 7-day share price return of 10.97% around the ABS-201 update and earnings sit against a 30-day share price decline of 11.23%, alongside a strong...

nCino (NCNO) has drawn fresh attention after introducing Model Context Protocol based AI tools inside its Mortgage Suite, giving lenders conversational interfaces that handle routine administrative and loan officer tasks and potentially reshape workflow efficiency. See our latest analysis for nCino. Against this product launch backdrop, nCino’s 1 month share price return of 12.77% and 3 month share price return of 24.98% sit alongside a year to date share price decline of 22.27% and a 1 year...

Palomar Holdings has delivered a very strong 144.6% return over the past 3 years, yet the stock now screens as overvalued on earnings-based measures and only earns a mixed overall value score. That combination raises the question of whether recent gains already reflect the key positives in the story. The 144.6% 3 year return suggests the market has rerated Palomar Holdings significantly and may now be pricing in optimistic expectations. Expectations for sustained profitable growth can...

PROCEPT BioRobotics (PRCT) stock is back in focus after the company reported second quarter 2026 results and reaffirmed full year guidance, highlighting higher HYDROS adoption alongside continued net losses. See our latest analysis for PROCEPT BioRobotics. Following the earnings release and reaffirmed guidance, PROCEPT BioRobotics has seen a short burst of optimism, with a 1-day share price return of 5.44% and a 7-day share price return of 25.22%. However, the 90-day share price return is...

With rate hike odds slipping, a softer jobs report and real wages falling behind inflation, the market is rethinking how to price reliable income and resilience. That shift can punish fragile business models and reward those that hold up when growth and policy look unsure. This article explains how that backdrop interacts with our Defensive Dividend and Consumer Staples Stocks screener and highlights 3 stocks that appear positively exposed to the latest Fed and inflation twist. The stocks...

In the past quarter, Ameren Corporation reported Q2 2026 revenue of US$2,092 million, down from US$2,221 million a year earlier, while net income rose to US$314 million and diluted EPS from continuing operations increased to US$1.13. Ameren also reaffirmed its full-year 2026 earnings guidance of US$5.25 to US$5.45 per share, highlighting management’s confidence despite softer top-line results. We’ll now examine how Ameren’s stronger earnings amid lower revenue and reaffirmed 2026 guidance...

NWPX Infrastructure stock has surged over the longer term, yet the current share price sits above the intrinsic value estimate from a Discounted Cash Flow (DCF) model and also screens as expensive on earnings multiples. Both valuation checks point in the same direction, which leaves the recent share price strength open to question. NWPX Infrastructure has returned about 329.7% over the past 5 years, which places a lot of market confidence into the current valuation. Expectations for...

Bond markets are reacting sharply to inflation data and oil prices, with several 10 year yields sitting near multi month extremes. When yields move, risk appetite often shifts quickly. That is where the Elite Penny Stocks screener comes in. It focuses on companies that still have cash to pursue their plans. This article highlights 3 of the most interesting stocks on that list for your watchlist. The three stocks below are only a sample of the companies that stood out, and the full screen...

Oil markets are back in the spotlight as Operation Economic Fury, tighter U.S. sanctions on Iran and disruption around the Strait of Hormuz squeeze global supply and feed into inflation worries. That mix can punish some stocks and support others, and sitting on the sidelines may mean missing important moves. This article looks at 3 integrated oil and gas producers that are directly exposed to these headlines. The 3 stocks below are just a small sample of the integrated producers on the radar,...

Cooling inflation in major economies is shifting attention back to growth stories. That includes the companies building the chips, software and cloud tools behind ChatGPT and other artificial intelligence systems. As investors weigh how rate paths might affect long term themes, AI stocks from this screener offer focused exposure to that trend. This article walks through three screen picks to help you assess if they fit your portfolio. The three stocks covered below are only a sample from this...